Cellectis (CLLS) Gross Profit Growth (1y) (2016 - 2023)
Cellectis (CLLS) Gross Profit Growth (1y) (2016 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cellectis |
17.40 Bn |
17.21 Bn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
176.19% |
| Sep 30, 2023 |
86.46% |
| Jun 30, 2023 |
-87.42% |
| Mar 31, 2023 |
-709.38% |
| Dec 31, 2022 |
168.85% |
| Sep 30, 2022 |
78.69% |
| Jun 30, 2022 |
269.20% |
| Mar 31, 2022 |
101.37% |
| Dec 31, 2021 |
97.97% |
| Sep 30, 2021 |
45.09% |
| Jun 30, 2021 |
80.25% |
| Mar 31, 2021 |
-105.15% |
| Dec 31, 2020 |
-145.08% |
| Sep 30, 2020 |
-138.79% |
| Jun 30, 2020 |
-968.55% |
| Mar 31, 2020 |
10,017.33% |
| Dec 31, 2019 |
-595.56% |
| Sep 30, 2019 |
11,034.21% |
| Jun 30, 2019 |
-95.67% |
| Mar 31, 2019 |
-91.76% |
